Clinical Trials Browser

Cystadenocarcinoma, Serous × ribociclib × 90 days × Clear all

NCT03673124 2025-12-23

Ribociclib and Letrozole Treatment in Ovarian Cancer

Phase 2 Active not recruiting

51 enrolled 19 charts

Cystadenocarcinoma, Serous